Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.75B |
| 2 |
Microsoft
MSFT
|
+$2.46B |
| 3 |
NVIDIA
NVDA
|
+$2.3B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.79B |
| 5 |
Amazon
AMZN
|
+$1.78B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$338M |
| 2 |
DAY
Dayforce
DAY
|
+$281M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$225M |
| 4 |
CYBR
CyberArk
CYBR
|
+$220M |
| 5 |
CMA
Comerica
CMA
|
+$213M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.41% |
| 2 | Financials | 12.78% |
| 3 | Consumer Discretionary | 9.97% |
| 4 | Healthcare | 9.79% |
| 5 | Communication Services | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
Outlook Therapeutics
OTLK
$263M
| $124K | ﹤0.01% |
603,606
+287,142
| +91% | +$124K |
|
|
QVCGA
4077
DELISTED
QVC Group Inc Series A
QVCGA
| $124K | ﹤0.01% |
56,949
-33,257
| -37% | -$202K |
|
|
GPAT
4078
GP-Act III Acquisition Corp
GPAT
$392M
| $124K | ﹤0.01% |
+11,395
| New | +$123K |
|
|
SCNX
4079
Scienture Holdings
SCNX
$15M
| $123K | ﹤0.01% |
432,186
+115,985
| +37% | +$53K |
|
4080
VerifyMe
VRME
$8.53M
| $123K | ﹤0.01% |
151,268
+43,916
| +41% | +$44.7K |
|
4081
MultiSensor AI
MSAI
$9.77M
| $122K | ﹤0.01% |
13,249
+3,162
| +31% | +$37.9K |
|
|
TBHC
4082
DELISTED
The Brand House Collective
TBHC
| $122K | ﹤0.01% |
131,637
+4,629
| +4% | +$5.11K |
|
|
MAMO
4083
Massimo Group
MAMO
$40.8M
| $122K | ﹤0.01% |
122,434
+46,940
| +62% | +$89K |
|
4084
Tenon Medical
TNON
$3.3M
| $122K | ﹤0.01% |
167,486
+100,846
| +151% | +$84.9K |
|
4085
CXApp
CXAI
$11.9M
| $121K | ﹤0.01% |
671,960
+464,533
| +224% | +$115K |
|
4086
GT Biopharma
GTBP
$11.7M
| $120K | ﹤0.01% |
294,459
+275,201
| +1,429% | +$150K |
|
|
LSH
4087
Lakeside Holding Ltd
LSH
$12.2M
| $120K | ﹤0.01% |
172,151
+102,251
| +146% | +$81.3K |
|
4088
PAVmed
PAVM
$33.9M
| $120K | ﹤0.01% |
11,777
+6,149
| +109% | +$58.2K |
|
4089
Air Industries Group
AIRI
$13.2M
| $119K | ﹤0.01% |
36,695
+9,195
| +33% | +$30.2K |
|
4090
Biomerica
BMRA
$4.9M
| $118K | ﹤0.01% |
56,042
+37,415
| +201% | +$85.5K |
|
4091
BioVie
BIVI
$10.3M
| $118K | ﹤0.01% |
84,203
+28,822
| +52% | +$37K |
|
|
LATA
4092
Galata Acquisition Corp II
LATA
$233M
| $117K | ﹤0.01% |
+11,760
| New | +$118K |
|
4093
Leslie's
LESL
$11.6M
| $117K | ﹤0.01% |
104,579
+18,730
| +22% | +$24.1K |
|
|
BCYC
4094
Bicycle Therapeutics
BCYC
$270M
| $117K | ﹤0.01% |
25,129
| – | – |
|
4095
Bolt Biotherapeutics
BOLT
$7.36M
| $116K | ﹤0.01% |
28,791
+9,988
| +53% | +$52K |
|
|
ATII
4096
Archimedes Tech SPAC Partners II Co
ATII
$316M
| $116K | ﹤0.01% |
+11,102
| New | +$117K |
|
4097
Jerash Holdings
JRSH
$58.8M
| $115K | ﹤0.01% |
39,763
-23,778
| -37% | -$74K |
|
|
OTLY
4098
Oatly Group
OTLY
$417M
| $114K | ﹤0.01% |
11,286
| – | – |
|
|
KBON
4099
Karbon Capital Partners Corp
KBON
$444M
| $114K | ﹤0.01% |
+11,366
| New | +$114K |
|
4100
BioCardia
BCDA
$12.7M
| $114K | ﹤0.01% |
94,287
+28,284
| +43% | +$35.4K |
|
Similar funds
Geode Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Geode Capital Management held 4,628 positions worth $1.61T, down 0.8% from $1.62T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Geode Capital Management deployed $55.8B of net new capital in Q1 2026, opening 160 new positions and adding to 3,465 existing holdings. Its largest new stake was Versant Media Group: 1,896,951 shares worth $70.3M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Hershey, an estimated $134M trimmed.
- Geode Capital Management's largest Q1 2026 buy was Versant Media Group: 1,896,951 shares worth $70.3M.
- Geode Capital Management added most to Apple in Q1 2026, an estimated $2.75B increase.
- Geode Capital Management's biggest Q1 2026 reduction was Hershey, cutting an estimated $134M.
- Geode Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $338M.
- Geode Capital Management's ten largest holdings make up 31% of its $1.61T portfolio in Q1 2026.
- Geode Capital Management opened 160 new positions and closed 115 in Q1 2026.
- Geode Capital Management's portfolio value fell 0.8% quarter-over-quarter to $1.61T.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.